Solène Q.
- Country
- France
- Department
- nuclear medicine unit
Research Overview
- Evaluation of diagnostic performances of 18F-FDOPA PET KInetics as biomarkers for the improvement of care of MRI Non-contrast enhanced Gliomas : a phase IIIb exploratory trial
- Phase IIb Trial of Everolimus and Lutetium (177Lu) Oxodotreotide in Refractory Grade 2 and 3 Meningioma
- Evaluation of 18F-Fludarabine PET in Initial and Relapsed Assessment of Symptomatic Multiple Myeloma Patients
Data & Insights
Has run more than one trial at 4 of 23 partner sites.
Specializations
Neuro-Oncology
The investigator specializes in advanced diagnostic and therapeutic approaches for brain tumors, particularly focusing on low-grade gliomas and meningiomas. Their expertise includes innovative imaging techniques and targeted treatments for complex neurological malignancies.
- Grade 2 and 3 Meningioma Management
- Glioma Characterization and Treatment
- Molecular-Based Brain Tumor Assessment
Nuclear Medicine Applications
The investigator employs advanced nuclear medicine techniques, including PET imaging and radioligand therapy. Their work encompasses various applications of radiopharmaceuticals for both diagnostic and therapeutic purposes.
- 18F-FDOPA PET Imaging
- 177Lu-DOTATATE Treatment
- 18F-Fludarabine PET Applications
Hematologic Oncology
The investigator's expertise extends to hematological malignancies, with particular emphasis on multiple myeloma. Their work involves innovative imaging approaches for assessment and monitoring of blood-based cancers.
- Multiple Myeloma Imaging
- Disease Assessment Methods
- Treatment Response Evaluation
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.